These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8413978

  • 1. End-of-dose dystonia in Parkinson's disease.
    Bravi D, Mouradian MM, Roberts JW, Davis TL, Chase TN.
    Neurology; 1993 Oct; 43(10):2130-1. PubMed ID: 8413978
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early morning dystonia in Parkinson's disease.
    Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF.
    Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC.
    Adv Neurol; 1990 Jul; 53():383-6. PubMed ID: 2122646
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P, Lenz FA, Chase TN.
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract] [Full Text] [Related]

  • 13. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 14. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
    Weiner WJ, Nausieda PA.
    Arch Neurol; 1982 Jul; 39(7):451-2. PubMed ID: 7103786
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T, Yahr MD.
    Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
    [Abstract] [Full Text] [Related]

  • 20. Levodopa-associated hemifacial dystonia.
    Mark MH, Sage JI.
    Mov Disord; 1991 Jan; 6(4):383. PubMed ID: 1758464
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.